Published in World J Gastroenterol on December 07, 2008
Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome. Arch Med Sci (2012) 0.79
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. J Clin Transl Hepatol (2015) 0.76
Effect of nitric oxide pathway regulation on water/sodium balance and renal function in a rodent model of acute liver and renal failure. Med Sci Monit (2014) 0.75
Liver transplantation from live donors. Lancet (1989) 2.98
Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63
Marginal hepatectomy in the rat: from anatomy to surgery. Ann Surg (2006) 1.31
Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology (2000) 1.17
Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension. Gut (2008) 1.09
Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest (2008) 1.03
Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats. J Pharm Pharmacol (2008) 1.00
Mitochondrial protection by low doses of insulin-like growth factor- I in experimental cirrhosis. World J Gastroenterol (2008) 0.98
Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats. Exp Toxicol Pathol (2006) 0.95
Problems with animal models of chronic liver disease: suggestions for improvement in standardization. Hepatology (1989) 0.94
Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of alpha-tocopherol on cirrhotic regeneration. J Surg Res (2000) 0.89
Inhibitory effect of olive oil on fibrosis induced by carbon tetrachloride in rat liver. Clin Nutr (2008) 0.88
Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Transplant Proc (2008) 0.86
Standardized micronodular cirrhosis in the rat. Eur Surg Res (1984) 0.85
Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation. Cell Transplant (2000) 0.84
Disturbance of hepatic and intestinal microcirculation in experimental liver cirrhosis. World J Gastroenterol (2005) 0.83
Hemodynamic effects of substance P and its receptor antagonist RP67580 in anesthetized rats with carbon tetrachloride-induced cirrhosis. Scand J Gastroenterol (2008) 0.82
Role of nitric oxide and endothelin-1 in a portal hypertensive rat model. Scand J Gastroenterol (2000) 0.81
Effect of preoperative interventions on outcome following liver resection in a rat model of cirrhosis. J Hepatol (2000) 0.81
Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res (1998) 0.81
Liver regeneration and the effect of exogenous putrescine on regenerative activity after partial hepatectomy in cirrhotic rats. Hepatology (1992) 0.81
[All out search of graft for liver transplantation]. Gastroenterol Clin Biol (1993) 0.78
Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis. Cell Transplant (2006) 0.78
Xenotransplantation. Br J Surg (1999) 0.78
[Transplantation of isolated hepatocytes. Principles, mechanisms, animal models, clinical results]. Gastroenterol Clin Biol (2002) 0.77
Transplantation of isolated hepatocytes. Indian J Gastroenterol (1985) 0.77
Liver regeneration following partial hepatectomy and stimulation by hepatic stimulatory substance in cirrhotic and non-cirrhotic rats. Res Exp Med (Berl) (1995) 0.77
[Gene therapy in Hepatology. Experimental results and clinical perspectives]. Gastroenterol Clin Biol (1994) 0.77
Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection. Xenotransplantation (2003) 0.77
miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A (2009) 4.15
Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res (2005) 3.12
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. J Hepatobiliary Pancreat Surg (2008) 2.40
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Laparoscopic living donor hepatectomy for liver transplantation in children. Lancet (2002) 2.15
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg (2014) 1.69
Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol (2003) 1.67
Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas. Pancreas (2008) 1.60
Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery? Arch Surg (2008) 1.58
Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: a comprehensive study of Caucasian non-smokers. Lung Cancer (2011) 1.58
Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg (2012) 1.53
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology (2010) 1.48
AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer (2010) 1.44
Removable intraductal stenting in duct-to-duct biliary reconstruction in liver transplantation. Transpl Int (2011) 1.42
Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation. World J Surg (2014) 1.42
Split liver transplantation using extended right grafts: the natural history of segment 4 and its impact on early postoperative outcomes. Liver Transpl (2012) 1.40
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl (2015) 1.38
European experience of laparoscopic major hepatectomy. J Hepatobiliary Pancreat Sci (2013) 1.33
Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut (2011) 1.33
Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg (2008) 1.32
Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg (2010) 1.27
International experience for laparoscopic major liver resection. J Hepatobiliary Pancreat Sci (2014) 1.23
Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology (2004) 1.21
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors. Cancer Res (2013) 1.17
Recurrent liver abscess secondary to ingested fish bone migration: report of a case. Surg Today (2008) 1.13
The role of biopsy of the nontumorous liver parenchyma in patients considered for partial resection of small hepatocellular carcinoma. Hepatology (2013) 1.08
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. Mutat Res (2008) 1.08
Major liver resection without clamping: a prospective reappraisal in the era of modern surgical tools. J Am Coll Surg (2004) 1.04
Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter study. Gastrointest Endosc (2010) 1.04
Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice. Gastroenterology (2010) 1.04
HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice. Hepatology (2005) 1.03
Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg (2011) 1.02
Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab Invest (2008) 1.00
Pure laparoscopic left lateral sectionectomy in living donors: from innovation to development in France. Ann Surg (2015) 0.99
Pancreatic fistula after pancreaticoduodenectomy: the conservative treatment of choice. HPB (Oxford) (2009) 0.99
Repeat sleeve gastrectomy compared with primary sleeve gastrectomy: a single-center, matched case study. Obes Surg (2012) 0.98
Laparoscopy Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection: A Propensity Score Analysis. Ann Surg (2016) 0.97
Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol (2007) 0.96
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways. Carcinogenesis (2012) 0.95
Three-dimensional computed tomography analysis of the left gastric vein in a pancreatectomy. HPB (Oxford) (2012) 0.95
Intraductal papillary mucinous tumors of the pancreas: features with multimodality imaging. J Comput Assist Tomogr (2002) 0.94
Totally laparoscopic right hepatectomy combined with resection of the inferior vena cava by anterior approach. Ann Surg Oncol (2014) 0.94
Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation (2003) 0.93
Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease. Eur Radiol (2014) 0.92
Thoracoscopic removal of mediastinal parathyroid glands: a critical appraisal of an emerging technique. Ann Surg (2010) 0.92
Multiplex target protein imaging in tissue sections by mass spectrometry--TAMSIM. Rapid Commun Mass Spectrom (2007) 0.91
Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl (2005) 0.91
A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J Med Virol (2007) 0.91
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Gastroenterology (2009) 0.90
Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. J Hepatol (2011) 0.88
Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl (2008) 0.88
Laparoscopic major hepatectomy for colorectal liver metastases in elderly patients: a single-center, case-matched study. Surg Endosc (2014) 0.87
[Acinar cystic transformation of the pancreas (or acinar cell cystadenoma), a rare and recently described entity]. Ann Pathol (2002) 0.87
Macrocystic form of serous pancreatic cystadenoma. Am J Gastroenterol (2002) 0.87
Feasibility of the Glissonian approach during right hepatectomy. HPB (Oxford) (2013) 0.87
Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding. Obes Surg (2009) 0.86
Safety of liver resection for hepatocellular carcinoma after sorafenib therapy: a multicenter case-matched study. Ann Surg Oncol (2013) 0.86
The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis. Clin Cancer Res (2013) 0.86
Congenital portosystemic shunts in children: a new anatomical classification correlated with surgical strategy. Ann Surg (2014) 0.86
Pathology report assessment of incidental gallbladder carcinoma diagnosed from cholecystectomy specimens: results of a French multicentre survey. Dig Liver Dis (2013) 0.85
Laparoscopic division of a portosystemic shunt to treat chronic hepatic encephalopathy. HPB (Oxford) (2008) 0.85
Lessons learned from the first 100 laparoscopic liver resections: not delaying conversion may allow reduced blood loss and operative time. J Laparoendosc Adv Surg Tech A (2012) 0.85
Patients with brain metastases from colorectal cancer are not condemned. Anticancer Res (2013) 0.85
Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection. World J Surg (2012) 0.85
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J (2007) 0.85
Improvements of TArgeted multiplex mass spectrometry IMaging. Proteomics (2008) 0.85
A comparative study of surgery and endoscopy for the treatment of bile duct stricture in patients with chronic pancreatitis. Surg Endosc (2012) 0.83
Modified Pringle maneuver for laparoscopic liver resection. Ann Surg Oncol (2014) 0.83
Glucose determination using a re-usable enzyme-modified ion track membrane sensor. Biosens Bioelectron (2008) 0.83
Sensitive detection of KRAS mutations using enhanced-ice-COLD-PCR mutation enrichment and direct sequence identification. Hum Mutat (2013) 0.83
Vessel identifications tags for open or laparoscopic associating liver partition and portal vein ligation for staged hepatectomy. J Am Coll Surg (2013) 0.83
Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases. Cancer Gene Ther (2004) 0.82
Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial. BMC Cancer (2014) 0.82
Gastrointestinal bleeding complication of gastric fistula after sleeve gastrectomy: consider pseudoaneurysms. Surg Endosc (2013) 0.81
Technique of open laparoscopy for supramesocolic surgery in obese patients. Surg Endosc (2010) 0.81
Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes. Transpl Int (2002) 0.81
CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation. Clin Transplant (2008) 0.80
Efficacy and safety of Celsior preservation fluid in liver transplantation: one-year follow up of a prospective, multicenter, non-randomized study. Clin Transplant (2011) 0.80
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. Transplantation (2007) 0.80
Liver repopulation trial using bone marrow cells in a retrorsine-induced chronic hepatocellular injury model. Gastroenterol Clin Biol (2006) 0.80
Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy. Ann Surg Oncol (2014) 0.79
Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? HPB (Oxford) (2013) 0.79
Pancreatic mucinous cystadenoma in an adult with cystic fibrosis. Clin Res Hepatol Gastroenterol (2011) 0.79
Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease? J Hepatol (2009) 0.79
Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors. Liver Transpl (2006) 0.79
Second and Third Laparoscopic Liver Resection for Patients With Recurrent Colorectal Liver Metastases. Ann Surg (2016) 0.78
Reducing biliary morbidity in full graft deceased donor liver transplantation: is it really a matter of T-tube? Ann Surg (2010) 0.78
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford) (2014) 0.78
Assessment of pathology reports on hilar cholangiocarcinoma: the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. J Hepatol (2012) 0.78
Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation. J Hepatol (2012) 0.77
Systemic sclerosis and gastric MALT lymphoma. Joint Bone Spine (2005) 0.77
Laparoscopic division of a portosystemic shunt for recurrent life-threatening rectal variceal bleeding: report of a case. J Gastrointest Surg (2013) 0.77
Biliary administration of naked DNA encoding Fas-Fc protein prevents acute liver failure in mice. Hum Gene Ther (2002) 0.77
[Transplantation of isolated hepatocytes. Principles, mechanisms, animal models, clinical results]. Gastroenterol Clin Biol (2002) 0.77
Insertion/deletion polymorphisms are convenient and reliable markers to assess chromosomal instability in human tumors. Int J Biol Markers (2012) 0.77